PIK3CA and cerebral cavernous malformation: Further follow‐up showed a stable number of lesions generated by the cooperative effect of the PIK3CA gain‐of‐function (GOF) after 3 months, highlighting that PIK3CA mutations are necessary synergistic factors in patients with CCM.